Literature DB >> 1759090

Insomnia and use of hypnotics: study of a French population.

M A Quera-Salva1, A Orluc, F Goldenberg, C Guilleminault.   

Abstract

A cross-sectional study of insomnia and hypnotic use was performed in a sample of the French population. The quota method was used to select the sample of 1,003 subjects, with less than 3% substitution. Subjects were 15 years old and older and were representative of the French population based on gender, age, marital status and living environment. Subjects were asked questions relevant to the complaint of insomnia and hypnotic use and filled out questionnaires measuring anxiety and depression. The complaint of insomnia is common, even in the 15-24-year-old group. Overall, more women than men were afflicted. The largest group of insomniac subjects, and the group who most often used hypnotics "frequently and chronically", were women 45 years and older. Men presented a sharp increase in hypnotic use after 65 years of age. Ten percent of the entire sample used hypnotics, 8% for more than 6 months and 6.17% on a chronic and frequent basis. Retired and unemployed elderly were also chronic and frequent hypnotic users: aging and social isolation correlate with chronic and frequent hypnotic usage. Higher scores on anxiety and depression scales correlate with more frequent complaints of nocturnal sleep disturbances. Young individuals are a significant complainer group but use hypnotics rarely. A rural environment was associated, overall, with fewer insomnia complaints, but environment had much less impact on complaints and hypnotic use in the elderly than in other age groups. One may question whether, in the French population, hypnotic prescription and intake are not responses to a social rather than a medical problem.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1759090     DOI: 10.1093/sleep/14.5.386

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  40 in total

1.  A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France.

Authors:  J Menzin; K M Lang; P Levy; E Levy
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

2.  Psychological treatment of insomnia in hypnotic-dependant older adults.

Authors:  James P Soeffing; Kenneth L Lichstein; Sidney D Nau; Christina S McCrae; Nancy M Wilson; R Neal Aguillard; Kristin W Lester; Andrew J Bush
Journal:  Sleep Med       Date:  2007-07-17       Impact factor: 3.492

3.  The effects of physical activity on sleep: a meta-analytic review.

Authors:  M Alexandra Kredlow; Michelle C Capozzoli; Bridget A Hearon; Amanda W Calkins; Michael W Otto
Journal:  J Behav Med       Date:  2015-01-18

4.  Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data.

Authors:  Nicholas T Vozoris; Richard S Leung
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

Review 5.  Women in clinical drug trials. An update.

Authors:  D L Schmucker; M S O'Mahony; E S Vesell
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

Review 6.  Sleep disorders in the elderly.

Authors:  R Asplund
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

7.  Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia.

Authors:  L Parrino; M C Spaggiari; M Boselli; G Di Giovanni; M G Terzano
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

Review 8.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26

9.  Insomnia and role impairment in the community : results from the Nigerian survey of mental health and wellbeing.

Authors:  Oye Gureje; Victor A Makanjuola; Lola Kola
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-04-21       Impact factor: 4.328

10.  Prevalence, types and possible causes of insomnia in a Swiss remand prison.

Authors:  Bernice S Elger
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.